Categories: Bitcoin

$700M BNB Move Fails to Save Windtree From Nasdaq Delisting



Windtree Therapeutics, a biotech firm that recently announced a $700 million BNB treasury strategy, has been delisted from Nasdaq for failing to meet a listing requirement. The BNB Inspired Rally and Subsequent Plunge Biotech company Windtree Therapeutics, which announced a massive $700 million BNB treasury move, has had its stock delisted from Nasdaq for failing […]



Source link

Joseph Rees

Leave a Comment
Share
Published by
Joseph Rees
3 hours ago

Recent Posts

Will NASDAQ Delisting Kill BNB Price Breakout?

Is the BNB price breakout dead? Windtree Therapeutics (WINT) shares collapsed 77% Wednesday after Nasdaq…

34 minutes ago

Anduril, Blue Origin to study how to transport cargo from orbit to Earth for the Pentagon

Blue Origin and Anduril have landed new study contracts with the U.S. Air Force to…

48 minutes ago

DOJ Paves Way for Decentralized Crypto With Major Win for Open Source Devs

The DOJ is boosting confidence across the crypto sector by affirming that decentralized software development…

50 minutes ago

Crypto Stocks Lose Steam After 500% Surge

Crypto equities, which had strongly outperformed Bitcoin over the past 18 months, are now showing…

2 hours ago

Anthropic Folds Claude Code Into Business Plans With Governance Tools

Anthropic added Claude Code to its Team and Enterprise subscriptions, alongside a new Compliance API…

2 hours ago

Winklevoss-backed Gemini gets EU-wide pass through Malta’s MiCA nod

Gemini is entering the European fray with a compliance-first advantage. Its newly granted MiCA license,…

3 hours ago